Diagnostics | Free Full-Text | Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
Frontiers | Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence | Oncogene
CDK4 and CDK6 kinases: From basic science to cancer therapy | Science
Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies | Acta Pharmacologica Sinica
Targeting CDK4/6 in patients with cancer - ScienceDirect
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers | npj Precision Oncology
CDK4/6 inhibitors induce tumor regression and increase antigen... | Download Scientific Diagram
Therapeutic potential of CDK4/6 inhibitors in renal cell carcinoma | Nature Reviews Urology
IJMS | Free Full-Text | The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases
IJMS | Free Full-Text | Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration
Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract | In Vivo
Frontiers | Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences | Drugs
Frontiers | CDK 4/6 inhibitors for the treatment of meningioma
IJMS | Free Full-Text | CDK4/6 Inhibitor Resistance in Hormone Receptor-Positive Metastatic Breast Cancer: Translational Research, Clinical Trials, and Future Directions
Treating cancer with selective CDK4/6 inhibitors | Nature Reviews Clinical Oncology
Discovery, Optimization, and Evaluation of Selective CDK4/6 Inhibitors for the Treatment of Breast Cancer | Journal of Medicinal Chemistry
Targeting CDK4/6 pathways and beyond in breast cancer - ScienceDirect
CDK4/6 inhibition in breast cancer: current practice and future directions - Sonia Pernas, Sara M. Tolaney, Eric P. Winer, Shom Goel, 2018
Cancers | Free Full-Text | CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
The Strange Case of CDK4/6 Inhibitors: Mechanisms, Resistance, and Combination Strategies: Trends in Cancer
Frontiers | CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors
Cells | Free Full-Text | Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
